Methods for monitoring platelet function

American Heart Journal

Volumn 135, Issue 5 II, 1998, Pages

  Cox, D ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 AMIDINOPHENOXY)BUTYRYLASPARTYLVALINE; ABCIXIMAB; FIBRINOGEN RECEPTOR ANTAGONIST; PENTAMIDINE; SKF 106760; TIROFIBAN; UNCLASSIFIED DRUG;

DRUG BLOOD LEVEL; HUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE RELEASE REACTION; THROMBOSIS;

EID: 0031807684     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-8703(98)70244-3     Document Type: Review

References (46)

1. W Siess Molecular mechanisms of platelet activation Physiol Rev 69 1989 58 178
2. M Lozano G Escolar J White D Tassies A Ordinas M Diaz-Ricart Redistribution of membrane glycoproteins in platelets activated under flow conditions Blood Coag Fibrinolysis 7 1996 214 217
3. D Cox T Aoki J Seki Y Motoyama K Yoshida The pharmacology of the integrins Med Res Rev 14 1994 195 228
4. J Lefkovits E Plow E Topol Mechanisms of disease: platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine New Engl J Med 332 1995 1553 1559
5. H Holmsen Platelet secretion and energy metabolism 3rd ed R Colman J Hirsh V Marder E Salzman Haemostasis and thrombosis: basic principles and clinical practice 1994 JB Lippincott Philadelphia S24 S45
6. K Ault J Mitchell H Rinder C Rinder R Hillman Analysis of platelets O Laerum R Jerkins Flow cytometry in hematology 1992 Academic Press 153 163
7. M Simoons M de Boer M van den Brand Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina Circulation 89 1994 596 603
8. B Coller L Scudder J Beer Monoclonal antibodies to platelet glycoprotein IIb/IIIa as antithrombotic agents Ann New York Acad Sci 614 1991 193 213
9. M Riederer B Steiner The extent of platelet aggregation is dependent on the free GPIIb/IIIa concentration and not the percent receptor occupancy Thromb Haemostas 77 1997 6
10. T Aoki D Cox K Senzaki The anti-platelet and anti-thrombotic effects of FK633, a peptide-mimetic GPIIb/IIIa antagonist Thromb Res 81 1996 439 450
11. D Cox Y Motoyama J Seki T Aoki M Dohi K Yoshida Pentamidine: a non-peptide GPIIb/IIIa antagonist. In vitro studies on platelets from humans and other species Thromb Haemostas 68 1992 731 736
12. D Cox T Aoki J Seki Y Motoyama K Yoshida Pentamidine is a specific, non-peptide, GPIIb/IIIa antagonist Thromb Haemostas 75 1996 503 509
13. S Kundu EJ Heilmann R Sio C Garcia RA Ostgaard Characterization of an in vitro platelet function analyzer, PFA-100 Clin Appl Thromb Haemostas 2 1996 241 249
14. S Goto D Salomon Y Ikeda Z Ruggeri Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets J Biol Chem 270 1995 23352 23361
15. Z Ruggeri The role of von Willebrand factor and fibrinogen in the initiation of platelet adhesion to thrombogenic surfaces Thromb Haemostas 74 1995 460 463
16. S Roux S Bunting W Kouns B Steiner Overdosing of potent GPIIb/IIIa antagonists differentially prolongs the bleeding time in guinea pigs [abstract] Thromb Haemostas 69 1993 560
17. M Bernardi R Califf N Kleiman S Ellis E Topol Lack of usefulness of prolonged bleeding times in predicting hemorrhagic events in patients receiving the 7E3 glycoprotein IIb/IIIa platelet antibody The TAMI Study Group Am J Cardiol 72 1993 1121 1125
18. R De Caterina M Lanza G Manca G Strata S Maffei L Salvatore Bleeding time and bleeding: an analysis of the relationship of the bleeding time test with parameters of surgical bleeding Blood 84 1994 3363 3370
19. I Besson N Hezard D Metz Monitoring of new therapeutical anti-GPIIb/IIIa using a quantitative flow cytometry method Thromb Haemostas 77 1997 8
20. T Ugarova A Budzynski S Shattil Z Ruggeri M Ginsberg E Plow Conformational changes in fibrinogen elicited by its interaction with platelet membrane glycoprotein GPIIb-IIIa J Biol Chem 268 1993 21080 21087
21. T Mondoro C Wall M White L Jennings Selective induction of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor Blood 88 1996 3824 3830
22. P Nurden M Humbert R Piotrowicz Distribution of ligand-occupied alpha IIb beta 3 in resting and activated human platelets determined by expression of a novel class of ligand-induced binding site recognized by monoclonal antibody AP6 Blood 88 1996 887 899
23. M Klinger H Kluter Immunocytochemical colocalization of adhesive proteins with clathrin in human blood platelets: further evidence for coated vesicle-mediated transport of von Willebrand factor, fibrinogen and fibronectin Cell Tissue Res 279 1995 453 457
24. M Blank D Cines G Arepally A Eldor A Afek Y Shoenfeld Pathogenicity of human anti-platelet factor 4 (PF4)/heparin in vivo: generation of mouse anti-PF4/heparin and induction of thrombocytopenia by heparin Clin Exp Immunol 108 1997 333 339
25. D Christie S Sauro A Cavanaugh M Kaplan Severe thrombocytopenia in an acuired immunodeficiency syndrome patient associated with pentamidine-dependent antibodies specific for glycoprotein IIb/IIIa Blood 82 1993 3075 3080
26. K Ault Flow cytometric analysis of platelets K Bauer R Duque T Shankey Clinical flow cytometry-principles and application 1993 Williams and Wilkins Baltimore 387 403
27. E Griffiths W Dzik Assays for heparin-induced thrombocytopenia Transfusion Med 7 1997 1 11
28. P Nguyen T Lecompte Heparin-induced thrombocytopenia: a survey of tests employed and attitudes in haematology laboratories Nouvelle Revue Francaise de Hematologie 36 1994 353 357
29. C Bihour C Durrieu-jais P Besse P Nurden A Nurden Flow cytometry reveals activated GP IIb-IIIa complexes on platelets from patients undergoing thrombolytic therapy after acute myocardial infarction Blood Coag Fibrinolysis 6 1995 395 410
30. R Scharf A Tomer U Marzec P Teirstein Z Ruggeri L Harker Activation of platelets in blood perfusing angioplasty-damaged coronary arteries Arerioscler Thromb 12 1992 1475 1487
31. D Fitzgerald L Roy F Catella G Fitzgerald Platelet activation in unstable coronary disease N Engl J Med 315 1986 983 989
32. E Mazoyer T Levy F Rendu KRDS, a new peptide derivative from human lactotransferrin, inhibits platelet aggregation and release reaction Eur J Biochem 194 1990 43 49
33. K Kaplan Laboratory markers of platelet activation R Colman J Hirsh V Marder E Salzman Haemostasis and thrombosis: basic principles and clinical practice 1994 JB Lippincott Philadelphia 1180 1196
34. H Suzuki M Packham R Kinlough-Rathbone Effects of thrombin and the thrombin receptor activating peptide, SFLLRN, on redistribution of platelet alpha-granule contents are similar and independent of the extent of thromboxane formation Exp Mol Pathol 62 1995 63 72
35. M Cahill M Macey A Newland Fixation with formaldehyde induces expression of activation dependent platelet membrane glycoproteins, P selectin (CD62) and GP53 (CD63) Br J Haematol 84 1993 527 529
36. E Kostelijk R Fijnheer H Nieuwenhuis C Gouwerok D de Korte Soluble P-selectin as parameter for platelet activation during storage Thromb Haemostas 76 1996 1086 1089
37. K Hamamoto S Ohga S Nomura K Yasunaga Cellular distribution of CD63 antigen in platelets and in three megakaryocytic cell lines Histochem J 26 1994 367 375
38. H Holmsen C Dangelmaier Measurement of secretion of serotonin Meth Enzymol 169 1989 205 210
39. JF Dong G Tung JA Lopez Role of glycoprotein V in the formation of the platelet high-affinity thrombin-binding site Blood 89 1997 4355 4363
40. C Ravanat M Freund A Azorza GP V is a marker of in vivo thrombin-induced platelet activation in a rat thrombosis model Thromb Haemostas 77 1997 473 474
41. P Holme U Orvim M Hamers Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis Arterio Thromb Vasc Biol 17 1997 646 653
42. Y Yano J Kambayashi T Kawasaki M Sakon Quantitative determination of circulating platelet microparticles by flow cytometry Int J Cardiol 47 1994 S13 S19
43. B Bouchard C Catcher B Thrash C Adida P Tracy Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation J Biol Chem 272 1997 9244 9251
44. S Abrams S Shattil Immunological detection of activated platelets in clinical disorders Thromb Haemostas 65 1991 467 473
45. F Silvestri A Masotti P Pradella F Zaja G Barillari L De Marco More on false thrombocytopenias: EDTA-dependent pseudothrombocytopenia associated with a congenital platelet release defect Vox Sang 71 1996 27 29
46. H Mukai H Kojima K Todokoro Serum thrombopoietin (TPO) levels in patients with amegakaryocytic thrombocytopenia are much higher than those with immune thrombocytopenic purpura Thromb Haemostas 76 1996 675 678